About

Provided by Kirkland & Ellis

Our capital markets team in Asia offers a full range of equity and debt capital markets products to our clients in the region, our cutting-edge advantages include over capital markets attorneys and legal professionals in the Hong Kong, Beijing and Shanghai offices working together as one team to provide a full spectrum of services to clients in the region, including HK IPOs, US IPOs, SPAC IPOs and other convertible bond, high yield and investment grade debt and follow-on offerings and PIPE transactions.


Recent work highlights include:


*Kirkland & Ellis advised Clover Biopharmaceuticals on its entry into a placing agreement.

*Kirkland & Ellis advised Vision Deal HK Acquisition Corp. on its listing of shares and warrants on the SEHK.

*Kirkland & Ellis advised Noah Holdings Limited on its global offering and secondary listing on the SEHK.


Chambers Review

Provided by Chambers
Capital Markets: Equity (International Firms) - China
2
Band 2
What the team is known for

Kirkland & Ellis offers a highly active ECM practice, much admired for its consistency and visibility on high-profile deals. The team has a strong track record of acting for international and local businesses and investment banks on US and Hong Kong IPOs. It additionally handles a range of secondary offerings in Hong Kong and New York and maintains strong relationships with regulators. As a Hong Kong and New York-qualified team with Chinese language capabilities, Kirkland & Ellis is well placed to advise on listings on a variety of stock exchanges. It often advises on significant deals in China's TMT and life sciences sectors. Key clients of the firm include L Catterton Asia Acquisition, Clover Biopharmaceuticals and Wynn Macau.

Work Highlights

Provided by Kirkland & Ellis
  • Kirkland & Ellis advised Yunkang Group on its USD140 million global offering and listing on the SEHK.

Strengths

Provided by Chambers

Notable Practitioners

Provided by Chambers
Mengyu Lu
3
Mengyu Lu
3
Band 3

Lu Mengyu has notable experience in acting for life sciences and biotech clients, with a strong track record of advising on 18A IPOs.

"Mengyu understands business and is hard-working, attentive to what customers think, enthusiastic, professional and creative."

"She's the best IPO lawyer I've had the pleasure to work with."

Ranked Lawyers at
Kirkland & Ellis

Provided by Chambers
Filter by
Band

China

Capital Markets: Equity (International Firms)

Mengyu Lu
3
Mengyu Lu
3
Band 3

Members

Provided by Kirkland & Ellis